Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2005
09/01/2005WO2005033314A3 Method for the production of a cell and/or tissue and/or disease phase specific medicament
09/01/2005WO2005030967A3 Crop plant cystatin proteinase inhibitors and methods of use
09/01/2005WO2005030966A3 Regulation of plant biomass and stress tolerance
09/01/2005WO2005026253A3 Labile linkage for compound delivery to a cell
09/01/2005WO2005024029A3 Plants having modified growth characteristics and method for making the same
09/01/2005WO2005002504A3 Protection against vertical transmission of pathogenic infections
09/01/2005WO2005001024A3 Genes encoding carotenoid compounds
09/01/2005WO2004106557A3 Thiamin production by fermentation
09/01/2005WO2004101809A3 Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
09/01/2005WO2004101746A3 Production of carotenoids in microorganisms
09/01/2005WO2004099387A3 siRNA INDUCED SYSTEMIC GENE SILENCING IN MAMMALIAN SYSTEMS
09/01/2005WO2004072282A9 Nephropathy-associated gene
09/01/2005WO2004056310A3 Methods of diagnosis and treatment of interstitial lung disease
09/01/2005WO2004053060A3 ANTISENSE MODULATION OF mitoNEET EXPRESSION
09/01/2005WO2004048512A3 Novel proteins and nucleic acids encoding same
09/01/2005WO2004044553A3 Lepidoptera voltage-gated calcium channels
09/01/2005WO2004033708A3 Methods and compositions for reducing screening in oligonucleotide-directed nucleic acid sequence alteration
09/01/2005WO2004024076A8 Novel compositions and methods for the treatment of immune related diseases
09/01/2005WO2003018759A3 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
09/01/2005WO2003013426A3 Multivalent synthetic vaccine for cancer
09/01/2005WO2002083873A3 Enzymes
09/01/2005US20050193447 Enhance drought tolerance of plant by transform with vector containing signal transduction polynucleotide sequence to produce a transgenic plant
09/01/2005US20050193446 Using vector transformation to generate seed with enhanced size/weight, carbon influx, fatty acid synthesis and oil content
09/01/2005US20050193445 Polynucleotides comprising nucleotide sequences and complements, that code gamma tocopherol methyltransferase polypeptides; transformation, genetic engineering
09/01/2005US20050193444 Modified maize comprising expression vector coding gene suppression agents which enhance lysisne biosynthesis
09/01/2005US20050193443 Using vector transformation to generate transgenic plants with enhanced resistance to drought and high environments
09/01/2005US20050193442 Soybean cultivar 70826751
09/01/2005US20050193441 For producing a disease resistant soybean plant
09/01/2005US20050193440 Soybean cultivar 0509246
09/01/2005US20050193439 Soybean cultivar 0509253
09/01/2005US20050193438 Plants exhibit male sterility, herbicide resistance, insect resistance, modified fatty acid metabolism, decreased phylate content, modified carbohydrate metabolism and resistance to bacterial disease, fungal disease or viral disease
09/01/2005US20050193437 Soybean cultivar 0509252
09/01/2005US20050193436 herbicide resistant, insect resistant, disease resistant transgenic plants and seeds
09/01/2005US20050193434 IL-21 as a regulator of immunoglobin production
09/01/2005US20050193433 Using nuclear receptor to identify modulators for controlling intestinal cholesterol adsorption
09/01/2005US20050193431 Somatic cell line
09/01/2005US20050192763 Method of selecting optimized SNP marker sets from multiple SNP markers associated with a complex disease
09/01/2005US20050192762 Method and apparatus for chemical genetic programming
09/01/2005US20050192428 Modified procollagen comprising collagen peptide chain and site-specific proteolytic agent recognition site for use preparation of biodegradable surical materials
09/01/2005US20050192242 Therapeutic fusion protein transgenes
09/01/2005US20050192238 Modulation of the expression of genes dependent on stat-1
09/01/2005US20050192237 Antisense antibacterial cell division composition and method
09/01/2005US20050191760 Hermatically sealed device comprising solid support for use in isolation of DNA from bodily fluids, wastes, excretions and blood
09/01/2005US20050191749 Novel plasmid vectors
09/01/2005US20050191747 Recombinant bovine immunodeficiency virus based gene transfer system
09/01/2005US20050191746 Compositions and methods for biodegradable polymer-peptide mediated transfection
09/01/2005US20050191740 Using tissue specific gene transfer element as tool in somatic gene therapy
09/01/2005US20050191739 Polyphenol oxidase genes from banana, lettuce, tobacco and pineapple
09/01/2005US20050191738 Modified reductase and its gene, and use thereof
09/01/2005US20050191737 Carcinostatic agent
09/01/2005US20050191736 Polypeptides having cellulolytic enhancing activity andpolynucleotides encoding same
09/01/2005US20050191735 Oxidoreductase
09/01/2005US20050191733 Nucleotide sequences coding glucose transport protein for use in enhancement of foods, cosmetic and animal feeds
09/01/2005US20050191732 Vector comprising nucleotide sequences coding homeostasis and adaptation (HA) proteins for use in enhancing/improving heterologous gene expression
09/01/2005US20050191731 Corelating phenotypic variance with genotypic polymorphism; bioinfomatics and disease treatment
09/01/2005US20050191729 Methods for the recombinant production of antifusogenic peptides
09/01/2005US20050191728 Connecting peptides (mini C-peptides) which confer an increased production yield in insulin derivatives when expressed in a transformed microorganism
09/01/2005US20050191727 Modified viral sequences which enhance genic expression in microorganismal host
09/01/2005US20050191726 Expression of heterologous multi-domain proteins in yeast
09/01/2005US20050191724 Nematode-extracted serine protease inhibitors and anticoagulant proteins
09/01/2005US20050191723 Improving gene expression in host cells vial use of vector comprising stabilizing anti-repressor (STAR) sequences; enhancer elements
09/01/2005US20050191722 Streptavidin-binding peptides and uses thereof
09/01/2005US20050191720 A vector for the surface expression of antibiotics composed of one or more genes that encode the synthetase and a gene encoding an amphiphilic peptide antibiotic having antibacterial, antifungal and anticancer activities; lactic acid-forming bacteria transformed with the vector
09/01/2005US20050191703 Bioassy for identifying compounds which prevent host proteins interation with viral protein associated with infection, replication, assembly or release; viricides
09/01/2005US20050191696 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
09/01/2005US20050191695 Documentation means for repertoires of NKR immunoreceptors and/or activatory or non-inhibitory immunoreceptor counterparts of NKR immunoreceptors
09/01/2005US20050191690 Membrane proteins for identifying modulators for prevention and treatment of infection, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
09/01/2005US20050191689 Novel nucleic acid base pair
09/01/2005US20050191688 Methods for making character strings, polynucleotides and polypeptides having desired characteristics
09/01/2005US20050191684 Transgenic gramnegative bacteria comprising enhanced 6-phosphogluconolactonase activity for fermentation of tryptophan, phenylalanine and tyrosine for use in cosmetics, medicine and animal feeds
09/01/2005US20050191680 Therapeutic nucleic acid-3' -conjugates
09/01/2005US20050191675 Methods of using an array of pooled probes in genetic analysis
09/01/2005US20050191673 Nucleotide sequences coding tumor marker genes for use as tool in classification, diagnosis and prognosis of cell proliferative disorders
09/01/2005US20050191672 Nucleotide sequences for use in controlling expression of serine/threonine kinase and treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular and skin disorders
09/01/2005US20050191666 Method of identification and cloning differentially expressed messenger RNAs
09/01/2005US20050191662 Peptide nucleic acid fusion for use in cell-free translation systems
09/01/2005US20050191659 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
09/01/2005US20050191658 Allelic series of genomic modifications in cells
09/01/2005US20050191653 Oligonucleotide for use in controlling expression of sodium-dependent glucose cotransporters (SGLT2) gene sequenes and treatment of diabetes
09/01/2005US20050191650 Used to reduce body temperature, suppress appetite, and therapy or prophylaxis of congestive heart failure and various stress-related disorders
09/01/2005US20050191649 Identifying mutation in oligoadenylate synthetase gene (OAS1); identifying modulators for prevention and treatment of cell proliferative, nervous system and diabetic disorders
09/01/2005US20050191648 Computer-directed assembly of a polynucleotide encoding a target polypeptide
09/01/2005US20050191641 Nucleotide sequences coding hydrolase for use as tool in identifying modulators for prevention and treatment of digestion, coagulation, diabetic, cell proliferative, urogenital, eating and nervous system gynecological disorders
09/01/2005US20050191639 Method to isolate genes involved in aging
09/01/2005US20050191638 Study and interfererance, diagnosis and treatment of polyglutamine using short interfering nucleic acid for treatment of dementia or siezures or muscular dystrophy
09/01/2005US20050191631 Screening compounds for centromere-associated protein E (CENP-E) activity by determining plus end-directed microtubule motor activity, ATPase activity, or microtubule binding activity of a candidate compound, especially on Xenopus CENP-E
09/01/2005US20050191626 Expression vector comprising gene fusion sequences for use in establishing correlation between genotype and phenotype in cell free expression systems
09/01/2005US20050191625 Polynucleotides for use as tags and tag complements, manufacture and use thereof
09/01/2005US20050191623 Nucleic acid cloning
09/01/2005US20050191622 Classifying human red blood cell (RBC) types; blood screening and transfusion
09/01/2005US20050191621 CD4-independent HIV envelope proteins as vaccines and therapeutics
09/01/2005US20050191619 Isolating nucleic acids from sources heavily contaminated with suspended solids and/or cellular debris
09/01/2005US20050191617 Pramyxovirusl vectors encoding antibody and utilization thereof
09/01/2005US20050191361 High-velocity particle injection techniques for transdermal or transmucosal delivery of a pharmacologically active agent using a hydrogel
09/01/2005US20050191317 Modified virus like particles; antiobesity agents
09/01/2005US20050191316 Neisseria genomic sequences and methods of their use
09/01/2005US20050191314 vaccine comprosing a mixture of A beta oligomers capable of generating an immune response; prophylaxis and treatment of Alzheimer's disease
09/01/2005US20050191303 Interleukin-18-binding protein
09/01/2005US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
09/01/2005US20050191292 of reversing cognitive decline by administering a humanized antibody that binds to A beta; particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease or Down's syndrome.
1 ... 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 ... 4023